Advances in Cancer Biomarkers
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 63
Special Issue Editor
Interests: clinical oncology; cancer biology; cancer diagnostics; metastasis; cancer biomarkers; molecular oncology; tumor biology; colorectal cancer; oncology
Special Issue Information
Dear Colleagues,
The Special Issue offers a deep exploration of the latest advancements in cancer biomarker research. It covers various topics, from discovering and validating novel biomarkers to their application in cancer diagnosis, prognosis, and treatment. The issue highlights the potential of biomarkers in improving early detection and personalized medicine for various types of cancer. We welcome contributors from diverse backgrounds, including oncology, genetics, and proteomics, to share their insights and expertise on the latest trends and challenges in the field. This Special Issue is a valuable resource for researchers, clinicians, and patients interested in understanding the role of biomarkers in cancer management and the future directions of this exciting area of research.
We welcome you to submit original research, comprehensive reviews, systematic reviews, brief reports, communications, interesting images, etc.
Dr. Simona Ruxandra Volovat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- tumor
- novel biomarkers
- diagnosis, prediction
- early detection
- prognosis
